M
Marco Salvetti
Researcher at Sapienza University of Rome
Publications - 294
Citations - 13327
Marco Salvetti is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 44, co-authored 263 publications receiving 10931 citations. Previous affiliations of Marco Salvetti include Max Planck Society & Istituto Neurologico Mediterraneo.
Papers
More filters
Journal ArticleDOI
Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
Maria Pia Amato,N. De Stefano,Matilde Inglese,Emanuele Morena,Giovanni Ristori,Marco Salvetti,Maria Trojano +6 more
TL;DR:
Journal ArticleDOI
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms
Maria Teresa Pascarelli,Claudio Del Percio,Maria Francesca De Pandis,Raffaele Ferri,Roberta Lizio,Giuseppe Noce,Susanna Lopez,Marco Rizzo,Andrea Soricelli,Flavio Nobili,Dario Arnaldi,Francesco Famà,Francesco Orzi,Carla Buttinelli,Franco Giubilei,Marco Salvetti,Virginia Cipollini,Raffaella Franciotti,Marco Onofri,Peter Fuhr,Ute Gschwandtner,Gerhard Ransmayr,Dag Aarsland,Lucilla Parnetti,Lucia Farotti,Moira Marizzoni,Fabrizia D'Antonio,Carlo de Lena,Bahar Güntekin,Lutfu Hanoglu,Görsev Yener,Derya Durusu Emek-Savaş,Antonio Ivano Triggiani,John-Paul Taylor,Ian G. McKeith,Fabrizio Stocchi,Laura Vacca,H. Hampel,Giovanni B. Frisoni,Laura Bonanni,Claudio Babiloni +40 more
TL;DR: Relevant clinical features were associated with abnormalities in spatial and frequency features of rsEEG source activities in DLB patients, and those features may be used as neurophysiological surrogate endpoints of clinical symptoms inDLB patients in future cross-validation prospective studies.
Journal ArticleDOI
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients
Gisella Guerrera,Alessandra Mandelli,Annamaria Finardi,Mario Orrico,Silvia D'Orso,Mario Picozza,Maddalena Noviello,Valeria Beretta,Bruno Bonetti,Massimiliano Calabrese,Damiano Marastoni,Nicola De Rossi,Ruggero Capra,Marco Salvetti,Maria Chiara Buscarinu,Matilde Inglese,Antonio Uccelli,Lucia Moiola,Catarina Raposo,Erwan Muros-Le Rouzic,Rosetta Pedotti,Massimo Filippi,Chiara Bonini,Luca Battistini,Giovanna Borsellino,Roberto Furlan +25 more
TL;DR: B-cell depletion using ocrelizumab does not impair the development of long-lasting anti-SARS-CoV-2 T-cell responses, and within naïve AIM+ CD4+ and CD8+ T-cells, the authors detected T memory stem cells, suggesting the acquisition ofLong-term memory.
Journal ArticleDOI
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases.
Rosella Mechelli,Silvia Romano,Carmela Romano,Emanuele Morena,Maria Chiara Buscarinu,Rachele Bigi,Gianmarco Bellucci,Roberta Reniè,Giulia Pellicciari,Marco Salvetti,Giovanni Ristori +10 more
TL;DR: In this article, the changes of mucosal-associated invariant T (MAIT) cells, as well as of the microbiota, in multiple sclerosis and other autoimmune disorders are analyzed.
Journal ArticleDOI
Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status
Federico Carlini,Federico Ivaldi,Francesca Gualandi,Ursula Boschert,Diego Centonze,Giuseppe Matarese,Marco Salvetti,Nicole Kerlero de Rosbo,Antonio Uccelli +8 more
TL;DR: In this article, the deoxycytidine kinase (dCK) and 5' deoxynucleotidase (NT5C2) were found to be more sensitive to 2CdA than other immune cells.